Amy Jordan Launches Grassroots Bid for NY-12 Congress Seat
February 10, 2026 — Amy Jordan announces grassroots campaign for Congress in NY-12, focusing on healthcare reform, education investment, and economic fairness. Learn more and get involved.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Rothman Orthopaedics Ranked #1 Nationwide for Top Orthopaedic Doctors
February 10, 2026 — Rothman Orthopaedics ranks #1 nationwide for Castle Connolly Top Doctors in orthopaedic care, with 92 physicians recognized across 10 specialties in PA, NJ, and FL.
New Resource Explores Link Between Depression and Physical Headache Pain
February 10, 2026 — Friendly Recovery Center releases educational blog on depression headaches, linking emotional distress to physical pain. Learn about symptoms and their mental health intensive outpatient program.
NJ Brain & Spine Ranked Among Top 3 Neurosurgical Practices in Nation
February 10, 2026 — New Jersey Brain & Spine ranks among the Top 3 neurosurgical practices in the US, recognized for its concentration of Castle Connolly Top Doctors and comprehensive care for brain & spine conditions.
LIXTE's LB-100 Compound Could Revolutionize Cancer Treatment Effectiveness
February 9, 2026 — LIXTE Biotechnology's LB-100 compound enhances cancer treatment effectiveness by inhibiting PP2A, potentially improving immunotherapy and chemotherapy outcomes for patients with resistant cancers.
LIXTE Acquires Liora's LiGHT System to Advance Cancer Therapy
February 9, 2026 — LIXTE Biotechnology acquires Liora Technologies and its LiGHT proton therapy system, enhancing cancer treatment with LB-100 synergy. Read the latest updates on this strategic move.
Oragenics Advances Intranasal Brain Therapy for Concussion Toward Phase 2 Trials
February 9, 2026 — Oragenics advances ONP-002, an intranasal neurosteroid for concussion treatment, toward Phase 2 trials in 2026. Learn about this potential first-in-class therapy and its impact on neurological care.
NHMS & Soring Partner on Ultrasonic Wound Debridement Technology
February 9, 2026 — New Horizon Medical Solutions partners with Soring to distribute ultrasonic wound debridement devices for chronic and acute wound treatment, enhancing patient outcomes through advanced technology.
DCS Rescue Clarifies Life-or-Death "Urgent vs Emergent" Move Distinction
February 9, 2026 — DCS Rescue releases a guide on urgent vs emergent moves in confined space rescue. Learn the critical distinction for patient extraction & responder safety in high-pressure emergency scenarios.
National Movement Demands HIPAA Reform for Families in Mental Health Crises
February 9, 2026 — Families Rights Matter2 movement advocates for HIPAA reform to help families during mental health emergencies. Learn about the petition on change.org and why current rules block critical information.
Creative Diagnostics Launches AI-Powered Infectious Disease Drug Discovery Platform
February 9, 2026 — Creative Diagnostics launches AI-powered infectious disease drug discovery platform combining AI with high-performance computing to accelerate antiviral research and combat antimicrobial resistance.
LIXTE's Novel Cancer Treatment Strategy Could Revolutionize Oncology
February 6, 2026 — LIXTE Biotechnology's LB-100 compound enhances cancer immunotherapy & chemotherapy effectiveness by targeting PP2A enzyme. Clinical trials show promise for ovarian & colon cancers.
LIXTE's Novel Cancer Strategy: Enhancing Existing Therapies with LB-100
February 6, 2026 — LIXTE Biotechnology advances cancer treatment with LB-100, a PP2A inhibitor designed to enhance existing immunotherapy and chemotherapy, targeting resistance in clinical trials for ovarian and colon cancers.
Soligenix Reports Positive Phase 2 Results for Behçet's Disease Treatment
February 6, 2026 — Soligenix announces positive Phase 2 results for SGX945 in Behçet's disease, a rare inflammatory condition. The novel therapy shows promise as a safe, immune-modulating treatment for underserved patients.
New Stroke Drug Loberamisal Shows 69% Recovery Rate in Trial
February 6, 2026 — Phase III trial shows loberamisal, a novel neuroprotective drug, improves stroke recovery with 69% excellent outcomes. Presented at American Stroke Association conference.
Breakthrough Therapy Shows Lasting Gains for Infants and Toddlers After Stroke
February 6, 2026 — New I-ACQUIRE therapy improves arm function in toddlers after stroke. High-dose, home-based treatment shows lasting benefits vs. usual care in a major clinical trial.
Lionheart Health & Rejuvant Partner in XPRIZE Healthspan Semi-Finals
February 6, 2026 — Lionheart Health partners with Rejuvant in XPRIZE Healthspan Semi-Finals, integrating CaAKG supplements with multi-modal healthspan optimization including personalized nutrition and bioelectric exercise.
Light-Activated Therapy Targets Residual Brain Cancer Cells in New Study
February 6, 2026 — New light-activated therapy targets microscopic brain cancer cells after surgery. Preclinical study shows promise for eliminating residual cancer tissue that surgeons cannot see during tumor removal.
Albrechtsen & Fanelli Orthodontics Brings Advanced MARPE Treatment to Utah
February 6, 2026 — Albrechtsen & Fanelli Orthodontics now offers MARPE treatment in Utah, a non-surgical solution for narrow palates in teens and adults. Learn about this advanced orthodontic care.
Doctors Prescribe 'Deeply Unimportant' Podcast for Sleep and Mental Calm
February 6, 2026 — Healthcare pros endorse Deeply Unimportant podcast for sleep aid, using cognitive shuffling to calm racing thoughts in ADHD/OCD. Hosted by ex-newscaster Dallas Kachan.